These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24052701)

  • 1. Aplasia ras homologous member I gene and development of glial tumors.
    Yakut S; Tuncer M; Berker M; Goksu E; Gurer I; Ozes O; Luleci G; Karauzum S
    Balkan J Med Genet; 2011 Jun; 14(1):37-44. PubMed ID: 24052701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Methylation in the CpG Island of the ARHI Promoter Region in Cancers.
    Liu X; Zhang T; Li Y; Zhang Y; Zhang H; Wang X; Li L
    Adv Exp Med Biol; 2020; 1255():123-132. PubMed ID: 32949395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis.
    Weber F; Aldred MA; Morrison CD; Plass C; Frilling A; Broelsch CE; Waite KA; Eng C
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1149-55. PubMed ID: 15546898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of ARHI in breast and ovarian cancer cells.
    Yu Y; Fujii S; Yuan J; Luo RZ; Wang L; Bao J; Kadota M; Oshimura M; Dent SR; Issa JP; Bast RC
    Ann N Y Acad Sci; 2003 Mar; 983():268-77. PubMed ID: 12724231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers.
    Yu Y; Luo R; Lu Z; Wei Feng W; Badgwell D; Issa JP; Rosen DG; Liu J; Bast RC
    Methods Enzymol; 2006; 407():455-68. PubMed ID: 16757345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells.
    Yang H; Lu X; Qian J; Xu F; Hu Y; Yu Y; Bast RC; Li J
    Mol Med Rep; 2010; 3(4):581-7. PubMed ID: 21472283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of ARHI expression in colon cancer and its clinical significance.
    Wang W; Chen L; Tang Q; Fan Y; Zhang X; Zhai J
    Contemp Oncol (Pozn); 2014; 18(5):329-33. PubMed ID: 25477755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
    Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
    J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss.
    Riemenschneider MJ; Reifenberger J; Reifenberger G
    Int J Cancer; 2008 Jun; 122(11):2503-10. PubMed ID: 18302158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.
    Chakraborty S; Mohiyuddin SM; Gopinath KS; Kumar A
    BMC Cancer; 2008 Jun; 8():163. PubMed ID: 18538015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer.
    Sørensen KD; Borre M; Ørntoft TF; Dyrskjøt L; Tørring N
    Int J Cancer; 2008 Feb; 122(3):509-19. PubMed ID: 17943724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of OPCML expression and the correlation with CpG island methylation and LOH in ovarian serous carcinoma.
    Chen H; Ye F; Zhang J; Lu W; Cheng Q; Xie X
    Eur J Gynaecol Oncol; 2007; 28(6):464-7. PubMed ID: 18179137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
    Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
    Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma.
    Huang Y; de la Chapelle A; Pellegata NS
    Int J Cancer; 2003 May; 104(6):735-44. PubMed ID: 12640681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
    Manjegowda MC; Gupta PS; Limaye AM
    Gene; 2017 May; 614():65-73. PubMed ID: 28286086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
    Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
    Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.